Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berwind Private Equity is a sixth-generation family-owned investment firm with a long-term buy-and-hold strategy. It maintains a diversified portfolio, including operating companies in pharmaceuticals (e.g., Colorcon), healthcare packaging (e.g., Oliver), medical technology, life sciences, and alternative investments in healthcare, technology, and financial technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berwind Private Equity.